1Brandes J L, Saper J R, Diamond M, et al. Topiramate for migraine prevention : a randomized controlled trial [ J ]. JAMA, 2004,25 (8) : 965 -973.
2Buzzi G M, Moskowitz M A. The pathophysiology of migraine :year 2005 [J]. J Headache Pain,2005,6(3) : 105- 111.
3Silberstein S D, Neto W, Schmitt J, et al. Topiramate in migraine prevention:results of a large controlled trial [J]. Arch Neurol, 2004,61 (4) :490-495.
4Olesen J. Calcium antagonists in migraine and vertigo, possible mechanisms of action and review of clinical trials [J]. Eur Neurdl, 1990,30(2) : 31-34.
9Brzoza Z, Grzeszczak W, Trautsolt W, et al. Lack of association of programmed cell death 1 gene( PDCD1 ) polymorphisms with sus- ceptibility to chronic urticaria in patients with positive autologous serum skin test [ J]. J Investig Allergol Clin lmmunol, 2012,22 (6) :432-436.
10Ue A P, Souza P K, Rotta O, et al. Quality of life assessment in pa- tients with chronic urticaria [ J ]. An Bras Dermatol, 2011,86 ( 5 ) : 897 -904.
